Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
13
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Navon Nadav | Chief Operating Officer | 3 | $0 | $0 | 2020-09-16 |
| Sassi Nir | Chief Financial Officer | 4 | $0 | $0 | 2020-09-16 |
| Linscott Walt Addison | Chief Business Officer | 4 | $0 | $0 | 2020-09-16 |
| Karah Hila | Director | 2 | $0 | $0 | 2020-07-15 |
| Pomerantz Roger | Director | 2 | $0 | $0 | 2020-07-15 |
| MADDALUNA ANTHONY J | Director | 3 | $11.8K | $0 | 2020-07-15 |
| Meckler Jeffrey A | Chief Executive Officer | 4 | $59.6K | $0 | 2020-07-15 |
| Hayes William B | Director | 2 | $0 | $0 | 2020-07-15 |
| KOZARICH JOHN W | Director | 2 | $46.0K | $0 | 2020-07-15 |
| GENDREAU R MICHAEL | Chief Medical Officer | 2 | $0 | $0 | 2020-02-17 |
| Dexcel Pharma Technologies Ltd. | 10% Owner | 3 | $0 | $282.5K | 2020-02-04 |
| Silberman Issac | Director | 2 | $0 | $500 | 2019-11-19 |
| Bianco Gil | Director | 1 | $0 | $0 | 2019-06-28 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Navon Nadav | Chief Operating Officer | A Award deriv | 2020-09-16 | 2020-09-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Linscott Walt Addison | Chief Business Officer | A Award deriv | 2020-09-16 | 2020-09-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Sassi Nir | Chief Financial Officer | A Award deriv | 2020-09-16 | 2020-09-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KOZARICH JOHN W | Director | A Award deriv | 2020-07-15 | 2020-07-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Hayes William B | Director | A Award deriv | 2020-07-15 | 2020-07-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Karah Hila | Director | A Award deriv | 2020-07-15 | 2020-07-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MADDALUNA ANTHONY J | Director | A Award deriv | 2020-07-15 | 2020-07-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Meckler Jeffrey A | Chief Executive Officer | A Award deriv | 2020-07-15 | 2020-07-17 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Pomerantz Roger | Director | A Award deriv | 2020-07-15 | 2020-07-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GENDREAU R MICHAEL | Chief Medical Officer | A Award deriv | 2020-02-17 | 2020-02-19 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Linscott Walt Addison | Chief Business Officer | A Award deriv | 2020-02-17 | 2020-02-19 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Navon Nadav | Chief Operating Officer | A Award deriv | 2020-02-17 | 2020-02-19 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Sassi Nir | Chief Financial Officer | A Award deriv | 2020-02-17 | 2020-02-19 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | S Sale | 2020-02-04 | 2020-02-04 | 110,000 | $0.29 | $31.9K | 4,234,897 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | S Sale | 2020-02-03 | 2020-02-04 | 80,000 | $0.32 | $25.6K | 4,344,897 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | S Sale | 2020-01-31 | 2020-02-04 | 725,951 | $0.31 | $225.0K | 4,424,897 | SEC↗ |
| Silberman Issac | Director | S Sale | 2019-11-19 | 2019-11-21 | 1,000 | $0.50 | $500 | 4,000 | SEC↗ |
| Linscott Walt Addison | Chief Business Officer | A Award deriv | 2019-09-13 | 2019-09-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Sassi Nir | Chief Financial Officer | A Award deriv | 2019-09-13 | 2019-09-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Meckler Jeffrey A | Chief Executive Officer | P Buy | 2019-08-28 | 2019-08-29 | 20,000 | $0.68 | $13.6K | 196,761 | SEC↗ |
| MADDALUNA ANTHONY J | Director | P Buy | 2019-08-27 | 2019-08-29 | 25,000 | $0.47 | $11.8K | 53,570 | SEC↗ |
| Meckler Jeffrey A | Chief Executive Officer | P Buy | 2019-08-23 | 2019-08-27 | 100,000 | $0.46 | $46.0K | 176,761 | SEC↗ |
| KOZARICH JOHN W | Director | P Buy | 2019-08-23 | 2019-08-27 | 100,000 | $0.46 | $46.0K | 151,761 | SEC↗ |
| Bianco Gil | Director | A Award deriv | 2019-06-28 | 2019-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Hayes William B | Director | A Award deriv | 2019-06-28 | 2019-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Karah Hila | Director | A Award deriv | 2019-06-28 | 2019-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MADDALUNA ANTHONY J | Director | A Award deriv | 2019-06-28 | 2019-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Pomerantz Roger | Director | A Award deriv | 2019-06-28 | 2019-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Silberman Issac | Director | A Award deriv | 2019-06-28 | 2019-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Meckler Jeffrey A | Chief Executive Officer | A Award deriv | 2019-04-04 | 2019-04-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Sassi Nir | Chief Financial Officer | A Award deriv | 2019-01-22 | 2019-01-23 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Navon Nadav | Chief Operating Officer | A Award deriv | 2019-01-22 | 2019-01-23 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Linscott Walt Addison | Chief Business Officer | A Award deriv | 2019-01-22 | 2019-01-23 | 90,000 | — | $0 | 90,000 | SEC↗ |
| GENDREAU R MICHAEL | Chief Medical Officer | A Award deriv | 2019-01-22 | 2019-01-23 | 110,000 | — | $0 | 110,000 | SEC↗ |